Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Cannabis Use Patterns Among Cancer Patients
A completed clinical trial update examining cannabis use patterns among cancer patients, sponsored by Thomas Jefferson University.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment [NA]
Completed clinical trial evaluating a food safety educational training program designed to improve food safety knowledge and behaviors in ca…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors [Phase 1]
This entry describes a Phase 1 clinical trial of SYS6040 for injection in patients with small cell lung cancer and other advanced solid tumo…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers [NA]
A clinical trial update from the National Cancer Center, Korea; the study is developing and recruiting for an intervention program to improv…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Evaluation of SYS6005 in Patients With Advanced Malignant Tumor [Phase 1]
Phase 1 study evaluating SYS6005 in adults with advanced malignant tumors, including B-cell malignancies and solid tumors. The trial is curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors [Phase 1]
Phase I clinical trial evaluating the safety, pharmacokinetics and antitumor activity of HC010 in patients with advanced solid tumors. The s…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion [Phase 1]
Phase I study of HSK41959 for advanced solid tumors with MTAP deletion is currently recruiting, indicating early-stage evaluation in this ge…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study to determine the maximum tolerated dose of PARPi 2X-121 as a monotherapy and in combination with dovitinib in patients with ad…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: NW-301 TCR-T in Patients With Advanced Solid Tumor [Phase 1]
This document describes a Phase 1 clinical trial of NW-301 TCR-T therapy in patients with advanced solid tumors; the study status is not yet…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors [Phase 1]
Phase I first-in-human study of GB268, a PD-1/CTLA-4/VEGF trispecific antibody, in patients with advanced solid tumors; trial status is not …
-
CLINICAL_TRIALS trial_result · 2025-04-28Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, pharmacodynamics, and immunogenicity of JNJ-63723283 as monotherapy or with Erdafitinib i…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: CLN-418 Study on Subjects With Advanced Solid Tumors [Phase 1]
The Phase 1 study of CLN-418 in subjects with advanced solid tumors has completed.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor [Phase 1]
A Phase 1 trial is evaluating the safety, tolerability, and pharmacokinetics of MPD-1 in patients with advanced solid tumors and is currentl…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors [Phase 1]
This document reports the completion of a Phase 1 safety study of GL-ONC1 in patients with advanced solid tumors.
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Application of the sG8 Scale in Real-World Geriatric Oncology Patients
A clinical trial update describing the real-world use of the sG8 scale to assess geriatric oncology patients with solid tumors; the study is…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 [Phase 1]
This Phase 1 study evaluated safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of NC762 in patients with advanced or metastatic solid tumors has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-90011 in participants with relapsed/refractory solid tumors and Non-Hodgkin lymphoma. Th…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Phase I Study of HS-20108 in Participants With Advanced Solid Tumors [Phase 1]
This document provides an update on a Phase I study of the investigational agent HS-20108 in participants with advanced solid tumors, which …
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients [Phase 1]
This Phase 1 clinical trial evaluates aprepitant for management of pruritus caused by immune checkpoint inhibitors in patients with solid tu…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Study of QLM2011 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for QLM2011 in subjects with advanced solid tumors; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors [Phase 2]
Phase 2 clinical trial update comparing telpegfilgrastim with filgrastim for secondary prevention of chemotherapy-induced neutropenia in ped…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors. [Phase 1]
An early-phase trial update describing safety, tolerability, pharmacokinetics and preliminary efficacy of BA1301 in patients with advanced s…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1 [Phase 1]
Phase 1 clinical trial evaluating the EpCAM-targeting imaging agent [99mTc]Tc(CO)3-(HE)3-Ec1 in adults with solid tumors has completed.